MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice.

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

"This work was supported by the grants from the 10.13039/501100001809National Natural Science Foundation of China (Grant No 81670069), the 10.13039/501100012166National Key Research and Development Program of China (Grant No 2018YFC1200302), the Natural Science Foundation of Hubei (Grant No 2019CFB679), the Health Commission of Hubei Province Scientific Research Project (Grant No WJ2021Q031) and the Teaching Research Project of Medical Department of Wuhan University (Grant No 2020078). We thank Prof. Hongliang Li (Wuhan University) for kindly providing the MNK2 deficient mice. Jianfeng Gao: Conceptualization, Investigation, Formal analysis, Validation, Data curation, Writing - original draft. Li Teng: Investigation, Methodology, Formal analysis, Validation, Data curation. Sijun Yang: Formal analysis, Methodology, Validation. Shuguang Huang: Investigation, Data curation, Methodology. Linrui Li: Methodology, Software, Investigation. Li Zhou: Investigation, Data curation. Guoquan Liu: Investigation, Data curation, Writing - original draft. Hongbin Tang: Resources, Supervision, Funding acquisition, Validation."